These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

555 related items for PubMed ID: 32295457

  • 1. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
    Devarakonda T, Mauro AG, Guzman G, Hovsepian S, Cain C, Das A, Praveen P, Hossain MA, Salloum FN.
    J Am Heart Assoc; 2020 Apr 21; 9(8):e015748. PubMed ID: 32295457
    [Abstract] [Full Text] [Related]

  • 2. Reperfusion therapy with recombinant human relaxin-2 (Serelaxin) attenuates myocardial infarct size and NLRP3 inflammasome following ischemia/reperfusion injury via eNOS-dependent mechanism.
    Valle Raleigh J, Mauro AG, Devarakonda T, Marchetti C, He J, Kim E, Filippone S, Das A, Toldo S, Abbate A, Salloum FN.
    Cardiovasc Res; 2017 May 01; 113(6):609-619. PubMed ID: 28073832
    [Abstract] [Full Text] [Related]

  • 3. Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes.
    Lieder HR, Braczko F, Gedik N, Stroetges M, Heusch G, Kleinbongard P.
    Basic Res Cardiol; 2021 Apr 19; 116(1):27. PubMed ID: 33876304
    [Abstract] [Full Text] [Related]

  • 4. Relaxin mitigates microvascular damage and inflammation following cardiac ischemia-reperfusion.
    Gao XM, Su Y, Moore S, Han LP, Kiriazis H, Lu Q, Zhao WB, Ruze A, Fang BB, Duan MJ, Du XJ.
    Basic Res Cardiol; 2019 Jun 19; 114(4):30. PubMed ID: 31218471
    [Abstract] [Full Text] [Related]

  • 5. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
    de Hoog VC, Bovens SM, de Jager SC, van Middelaar BJ, van Duijvenvoorde A, Doevendans PA, Pasterkamp G, de Kleijn DP, Timmers L.
    Cardiovasc Res; 2015 Dec 01; 108(3):367-76. PubMed ID: 26449403
    [Abstract] [Full Text] [Related]

  • 6. Sodium 4-Phenylbutyrate Attenuates Myocardial Reperfusion Injury by Reducing the Unfolded Protein Response.
    Takatori O, Usui S, Okajima M, Kaneko S, Ootsuji H, Takashima SI, Kobayashi D, Murai H, Furusho H, Takamura M.
    J Cardiovasc Pharmacol Ther; 2017 May 01; 22(3):283-292. PubMed ID: 27909014
    [Abstract] [Full Text] [Related]

  • 7. Remifentanil Induces Cardio Protection Against Ischemia/Reperfusion Injury by Inhibiting Endoplasmic Reticulum Stress Through the Maintenance of Zinc Homeostasis.
    Sheng M, Zhang G, Wang J, Yang Q, Zhao H, Cheng X, Xu Z.
    Anesth Analg; 2018 Jul 01; 127(1):267-276. PubMed ID: 29771714
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
    Wang H, Zhao YT, Zhang S, Dubielecka PM, Du J, Yano N, Chin YE, Zhuang S, Qin G, Zhao TC.
    J Cell Physiol; 2017 Dec 01; 232(12):3775-3785. PubMed ID: 28181692
    [Abstract] [Full Text] [Related]

  • 10. Obestatin affords cardioprotection to the ischemic-reperfused isolated rat heart and inhibits apoptosis in cultures of similarly stressed cardiomyocytes.
    Alloatti G, Arnoletti E, Bassino E, Penna C, Perrelli MG, Ghé C, Muccioli G.
    Am J Physiol Heart Circ Physiol; 2010 Aug 01; 299(2):H470-81. PubMed ID: 20525876
    [Abstract] [Full Text] [Related]

  • 11. Recombinant Extracellular Domain (p75ECD) of the Neurotrophin Receptor p75 Attenuates Myocardial Ischemia-Reperfusion Injury by Inhibiting the p-JNK/Caspase-3 Signaling Pathway in Rat Microvascular Pericytes.
    Fang J, Wei Z, Zheng D, Ying T, Hong H, Hu D, Lin Y, Jiang X, Wu L, Lan T, Yang Z, Zhou X, Chen L.
    J Am Heart Assoc; 2020 Jul 07; 9(13):e016047. PubMed ID: 32567476
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. High-dose Humanin analogue applied during ischemia exerts cardioprotection against ischemia/reperfusion injury by reducing mitochondrial dysfunction.
    Thummasorn S, Shinlapawittayatorn K, Chattipakorn SC, Chattipakorn N.
    Cardiovasc Ther; 2017 Oct 07; 35(5):. PubMed ID: 28726291
    [Abstract] [Full Text] [Related]

  • 14. Melatonin Receptor Agonist Ramelteon Reduces Ischemia-Reperfusion Injury Through Activation of Mitochondrial Potassium Channels.
    Stroethoff M, Christoph I, Behmenburg F, Raupach A, Bunte S, Senpolat S, Heinen A, Hollmann MW, Mathes A, Huhn R.
    J Cardiovasc Pharmacol; 2018 Aug 07; 72(2):106-111. PubMed ID: 29787401
    [Abstract] [Full Text] [Related]

  • 15. Potential role of EphrinA2 receptors in postconditioning induced cardioprotection in rats.
    Kaur K, Singh N, Dhawan RK.
    Eur J Pharmacol; 2020 Sep 15; 883():173231. PubMed ID: 32589885
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Metformin protects against myocardial ischemia-reperfusion injury and cell pyroptosis via AMPK/NLRP3 inflammasome pathway.
    Zhang J, Huang L, Shi X, Yang L, Hua F, Ma J, Zhu W, Liu X, Xuan R, Shen Y, Liu J, Lai X, Yu P.
    Aging (Albany NY); 2020 Nov 24; 12(23):24270-24287. PubMed ID: 33232283
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Endogenous angiotensin-(1-7)/Mas receptor/NO pathway mediates the cardioprotective effects of pacing postconditioning.
    Abwainy A, Babiker F, Akhtar S, Benter IF.
    Am J Physiol Heart Circ Physiol; 2016 Jan 01; 310(1):H104-12. PubMed ID: 26519026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.